医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Physitrack: Gensolve Launches New Zealand’s Biggest Telehealth Initiative

2016年11月08日 PM08:39
このエントリーをはてなブックマークに追加


 

AUCKLAND, New Zealand

Gensolve Practice Manager, the leading practice management software provider to New Zealand Allied Health professionals, covering over 90% of the market, today announces the launch of a unique patient engagement toolkit inside its practice management solution GPM that combines clinical exercise provision, outcomes analysis, patient education and Telehealth in one easy to use ecosystem.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161108005551/en/

Gensolve’s uniquely integrated Telehealth solution allows physiotherapists to stream exercise demons ...

Gensolve’s uniquely integrated Telehealth solution allows physiotherapists to stream exercise demonstration videos and track outcomes while engaging with patients on a secure video call. (Business Wire)

This digital patient engagement solution, developed by Physitrack, one of the very few companies in the digital healthcare industry that Apple is collaborating closely with, will make it possible for Allied Health providers in New Zealand to extend the scope of their work to offer smartphone, tablet and computer-based video consultations before, during or after in-patient treatments.

Danny Trigg, Director Gensolve Practice Manager: “This is the first time both patient engagement and secure video consultations have been combined inside a practice management system in this way. Gensolve are excited to be able to offer New Zealand’s healthcare practitioners this innovative technology, which is designed to enhance patient journeys and improve outcomes. Practitioners will be able to conduct patient consultations regardless of their location, all initiated from within Gensolve.

Henrik Molin, CEO & co-founder of Physitrack: “While digital in-practice and remote care are on the agenda of private and public healthcare systems all over the world, very few countries have managed wide implementation of easily accessible and working solutions. Gensolve’s innovative move today, that provides this unique combination of digital home exercise provision and Telehealth technology to what is in effect 90% of the New Zealand market, is groundbreaking and we are very excited to be part of this historical move.”

Starting in December, all of Gensolve’s GPM customers in New Zealand will have access to Physitrack at no additional charge to their GPM subscriptions from within GMP. A minimal per minute call charge will be introduced to GPM users in the coming months for using the Telehealth feature.

About Gensolve Practice Manager

Gensolve Practice Manager is New Zealand’s leading practice management platform. Released in 2001, Gensolve is a cloud-based, Practice Management Software provider for Allied Health businesses. They offer leading cloud-based solutions to physiotherapy and podiatry clinics, including comprehensive KPI Reporting, advanced custom forms and patient records, integrated accounting, inventory management, plus much more to encompass the entire business work flow.

About Physitrack

Physitrack is a privately held UK company with offices in Melbourne, Santa Monica, Houston, London, Amsterdam and New Delhi. The company provides healthcare companies with an easy to use patient engagement solution for clinical home exercise prescription and patient education, patient outcomes tracking and secure Telehealth video consultations.

Physitrack is amongst a select group of e-health solution developers with which Apple (NASDAQ: AAPL) has announced collaboration.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161108005551/en/

CONTACT

Physitrack
Marijn Kortekaas
Partner and Program
Director Asia Pacific
mk@physitrack.com.au
+61401869207
or
Gensolve
Jessica
Jasch
Marketing Co-Ordinator, Gensolve Practice Manager
jessica.jasch@gensolve.com

同じカテゴリーの記事 

  • joimax® Obtains Registration for All Products in the Indian Market
  • Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China
  • Inocras Pioneers Precision Health with Revolutionary Whole Genome Insights
  • エクセルゲン、バクスター・インターナショナルを提訴。口腔体温計の精度に関するデータの公表権を擁護
  • パース・バイオサイエンシズが研究室用自動化プロバイダー・プログラムをローンチし、ハミルトン、オープントロンズ、ラボワークス、SPTラボテックと提携